Celldex Therapeutics earnings were -$150.2M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest CLDX earnings report on Jun 30, 2024 announced Q2 2024 earnings of -$35.8M, up 9.2% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, CLDX reported annual earnings of -$141.4M, with 25.9% growth. The next CLDX earnings date is Oct 31, 2024.
Celldex Therapeutics Earnings Reports & History FAQ
What were Celldex Therapeutics's earnings last quarter?
On CLDX's earnings call on Invalid Date, Celldex Therapeutics (NASDAQ: CLDX) reported Q2 2024 earnings per share (EPS) of -$0.54, up 16.92% year over year. Total CLDX earnings for the quarter were -$35.84 million. In the same quarter last year, Celldex Therapeutics's earnings per share (EPS) was -$0.65.
The next CLDX earnings date is Invalid Date. Add CLDX to your watchlist to be reminded of Celldex Therapeutics's next earnings date.
What was CLDX's earnings growth in the past year?
As of Celldex Therapeutics's earnings date in Invalid Date, Celldex Therapeutics's earnings has grown year over year. CLDX earnings in the past year totalled -$150.22 million.
Is Celldex Therapeutics profitable or losing money?
As of the last Celldex Therapeutics earnings report, Celldex Therapeutics is currently losing money. Celldex Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$150.22 million, a 32.78% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.